Pharmacological and clinical applications of natriuretic peptides: Accepted knowledges or changing views?

Izzi Valerio, Chiurchiù Valerio, Baldini P. Morena

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Natriuretic peptides (NPs) are endegenous low molecular weight peptides known for their hypotensive activities. Due to their ability to induce both natriuresis (Na+ secretion) and diuresis, in fact, these peptides can profoundly decrease the body haemodynamic load, an effect which represents a main goal for all therapies aiming at improving the health of those subjects affected by different forms of heart and kidney failure. Over the years, many evidences have been provided for the involvement of NPs in the control of different cardiovascular parameters both in physiological and pathological conditions, This has led many researchers to test the possible therapeutic effects of different NPs and the pharmacological industries to develop exogenous NPs forms with a higher activity. This review aims then at summarizing the current knowledge about the therapeutic and clinical applications of NPs, also considering "atypical" NPs and the problems yet to be solved.

Original languageEnglish
Pages (from-to)195-204
Number of pages10
JournalCurrent Pharmaceutical Analysis
Volume3
Issue number3
DOIs
Publication statusPublished - Aug 2007

Fingerprint

Natriuretic Peptides
Pharmacology
Natriuresis
Peptides
Diuresis
Hemodynamics
Therapeutic Uses
Renal Insufficiency
Industry
Heart Failure
Molecular Weight
Molecular weight
Research Personnel
Health
Therapeutics

Keywords

  • C-type Natriuretic Peptide
  • Congestive heart failure
  • Dendroaspis Natriuretic Peptide
  • Neutral endopeptidase 24.11
  • NPPB gene

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Pharmacological and clinical applications of natriuretic peptides : Accepted knowledges or changing views? / Valerio, Izzi; Valerio, Chiurchiù; Morena, Baldini P.

In: Current Pharmaceutical Analysis, Vol. 3, No. 3, 08.2007, p. 195-204.

Research output: Contribution to journalArticle

@article{4aa71989d38c49b68477f2965ff02f76,
title = "Pharmacological and clinical applications of natriuretic peptides: Accepted knowledges or changing views?",
abstract = "Natriuretic peptides (NPs) are endegenous low molecular weight peptides known for their hypotensive activities. Due to their ability to induce both natriuresis (Na+ secretion) and diuresis, in fact, these peptides can profoundly decrease the body haemodynamic load, an effect which represents a main goal for all therapies aiming at improving the health of those subjects affected by different forms of heart and kidney failure. Over the years, many evidences have been provided for the involvement of NPs in the control of different cardiovascular parameters both in physiological and pathological conditions, This has led many researchers to test the possible therapeutic effects of different NPs and the pharmacological industries to develop exogenous NPs forms with a higher activity. This review aims then at summarizing the current knowledge about the therapeutic and clinical applications of NPs, also considering {"}atypical{"} NPs and the problems yet to be solved.",
keywords = "C-type Natriuretic Peptide, Congestive heart failure, Dendroaspis Natriuretic Peptide, Neutral endopeptidase 24.11, NPPB gene",
author = "Izzi Valerio and Chiurchi{\`u} Valerio and Morena, {Baldini P.}",
year = "2007",
month = "8",
doi = "10.2174/157341207781369376",
language = "English",
volume = "3",
pages = "195--204",
journal = "Current Pharmaceutical Analysis",
issn = "1573-4129",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Pharmacological and clinical applications of natriuretic peptides

T2 - Accepted knowledges or changing views?

AU - Valerio, Izzi

AU - Valerio, Chiurchiù

AU - Morena, Baldini P.

PY - 2007/8

Y1 - 2007/8

N2 - Natriuretic peptides (NPs) are endegenous low molecular weight peptides known for their hypotensive activities. Due to their ability to induce both natriuresis (Na+ secretion) and diuresis, in fact, these peptides can profoundly decrease the body haemodynamic load, an effect which represents a main goal for all therapies aiming at improving the health of those subjects affected by different forms of heart and kidney failure. Over the years, many evidences have been provided for the involvement of NPs in the control of different cardiovascular parameters both in physiological and pathological conditions, This has led many researchers to test the possible therapeutic effects of different NPs and the pharmacological industries to develop exogenous NPs forms with a higher activity. This review aims then at summarizing the current knowledge about the therapeutic and clinical applications of NPs, also considering "atypical" NPs and the problems yet to be solved.

AB - Natriuretic peptides (NPs) are endegenous low molecular weight peptides known for their hypotensive activities. Due to their ability to induce both natriuresis (Na+ secretion) and diuresis, in fact, these peptides can profoundly decrease the body haemodynamic load, an effect which represents a main goal for all therapies aiming at improving the health of those subjects affected by different forms of heart and kidney failure. Over the years, many evidences have been provided for the involvement of NPs in the control of different cardiovascular parameters both in physiological and pathological conditions, This has led many researchers to test the possible therapeutic effects of different NPs and the pharmacological industries to develop exogenous NPs forms with a higher activity. This review aims then at summarizing the current knowledge about the therapeutic and clinical applications of NPs, also considering "atypical" NPs and the problems yet to be solved.

KW - C-type Natriuretic Peptide

KW - Congestive heart failure

KW - Dendroaspis Natriuretic Peptide

KW - Neutral endopeptidase 24.11

KW - NPPB gene

UR - http://www.scopus.com/inward/record.url?scp=34548294933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548294933&partnerID=8YFLogxK

U2 - 10.2174/157341207781369376

DO - 10.2174/157341207781369376

M3 - Article

AN - SCOPUS:34548294933

VL - 3

SP - 195

EP - 204

JO - Current Pharmaceutical Analysis

JF - Current Pharmaceutical Analysis

SN - 1573-4129

IS - 3

ER -